Nonprofit drugmaker Civica Rx is taking aim at the high insulin prices harming people with diabetes
- Written by Jing Luo, Assistant Professor of Medicine, University of Pittsburgh Health Sciences
High insulin prices are leaving some people who need the drug without access.Erik McGregor/LightRocket via Getty ImagesDoctors have been treating diabetes with insulin since 1922. A century later, about 1 in 5 of the 37 million Americans living with diabetes take this medication – a hormone that helps cells absorb sugar from the blood.
This...

